Dean Margeson

<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Guido Marcucci, Kati Maharry, Yue-Zhong Wu et al. · Journal of Clinical Oncology · 2010 · 764 citations · Full text

Medicine, Hematology, Oncology +17

Growth and Development in Preterm Infants Fed Long-Chain Polyunsaturated Fatty Acids: A Prospective, Randomized Controlled Trial

Deborah L. O’Connor, Robert T. Hall, David H. Adamkin et al. · PEDIATRICS · 2001 · 390 citations

Medicine, Nutrition, Nutritional Sciences +17

Favorable Prognostic Impact of <i>NPM1</i> Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study

Heiko Becker, Guido Marcucci, Kati Maharry et al. · Journal of Clinical Oncology · 2009 · 339 citations · Full text

Medicine, Molecular Genetics, Oncology +17

<i>TET2</i> Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Klaus H. Metzeler, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2011 · 320 citations · Full text

Medicine, Molecular Genetics, Oncology +17

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Susan P. Whitman, Kati Maharry, Michael D. Radmacher et al. · Blood · 2010 · 230 citations · Full text

Life Sciences, Genetics, Oncology +16